SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001867096-22-000040
Filing Date
2022-03-11
Accepted
2022-03-11 07:47:51
Documents
93
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K xers-20211231.htm   iXBRL 10-K 2318441
2 EX-4.3 xeris-ex43xdescriptionofse.htm EX-4.3 45058
3 EX-21.1 xeris-ex211xlistofsubsidia.htm EX-21.1 4859
4 EX-23.1 a202110-kexhibit231.htm EX-23.1 2227
5 EX-31.1 a202110-kexhibit311.htm EX-31.1 10205
6 EX-31.2 a202110-kexhibit312.htm EX-31.2 10088
7 EX-32.1 a202110-kexhibit321.htm EX-32.1 5693
8 EX-32.2 a202110-kexhibit322.htm EX-32.2 5398
14 xers-20211231_g1.jpg GRAPHIC 58702
15 xers-20211231_g2.jpg GRAPHIC 43830
  Complete submission text file 0001867096-22-000040.txt   9976256

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xers-20211231.xsd EX-101.SCH 66838
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT xers-20211231_cal.xml EX-101.CAL 62641
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT xers-20211231_def.xml EX-101.DEF 325689
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xers-20211231_lab.xml EX-101.LAB 859433
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xers-20211231_pre.xml EX-101.PRE 539935
87 EXTRACTED XBRL INSTANCE DOCUMENT xers-20211231_htm.xml XML 1398587
Mailing Address 180 N. LASALLE STREET, SUITE 1600 CHICAGO IL 60601
Business Address 180 N. LASALLE STREET, SUITE 1600 CHICAGO IL 60601 844-445-5704
Xeris Biopharma Holdings, Inc. (Filer) CIK: 0001867096 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40880 | Film No.: 22731162
SIC: 2834 Pharmaceutical Preparations